🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kristie A. Blum

Emory University

ORCID: 0000-0003-4229-2569

Also affiliated with Piedmont Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study”.

Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2856
N/A
4.5DataRank · unranked
184 citations

Richard R. Furman, Steven Coutré, Ian W. Flinn, Jan A. Burger, Kristie A. Blum +9 more

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2405888
N/A
3.4DataRank · unranked
211 citations

Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens +42 more

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30067-3
N/A
0.510DataRank · unranked
29 citations

John P. Leonard, Thomas E. Witzig, Thomas M. Habermann, Kristie A. Blum, Nancy L. Bartlett +8 more

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Hematological Oncology(2023)10.1002/hon.3163_5
N/A
0.464DataRank · unranked
21 citations

Michael LeBlanc, Sharon M. Castellino, Huilin Li, Sarah C. Rutherford, Andrew M. Evens +41 more

Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0471
N/A
0.312DataRank · unranked
7 citations

Akil Akhtar, Lilin Lai, Victor M. Orellana‐Noia, Susanne L. Linderman, Ashley A. McCook‐Veal +21 more

Relevance of bone marrow biopsies for response assessment in NCTN follicular lymphoma clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8038
N/A
0.104DataRank · unranked
1 citations

Jun Yin, Levi Pederson, Betsy LaPlant, Mazyar Shadman, Hongli Li +15 more

Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma

Blood Advances(2024)10.1182/bloodadvances.2023012090
N/A
0DataRank · unranked
2 citations

Jun Yin, Levi Pederson, Kristie A. Blum, Peter Martin, Sin‐Ho Jung +7 more

Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103

UNC Libraries(2020)10.17615/mbvm-5959
N/A
0DataRank · unranked
0 citations

Bruce D. Cheson, Matthew S. Davids, Kristie A. Blum, Sonali M. Smith, Steven I. Park +10 more

Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study

Haematologica(2021)10.3324/haematol.2020.270876
N/A
0DataRank · unranked
42 citations

Andrew M. Evens, Alexey V. Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie +52 more

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Blood Advances(2021)10.1182/bloodadvances.2021004765
N/A
0DataRank · unranked
41 citations

Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie +30 more

Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Journal of Clinical Oncology(2022)10.1200/jco.22.00088
N/A
0DataRank · unranked
40 citations

Akil Akhtar, Susanne L. Linderman, Lilin Lai, Victor M. Orellana‐Noia, Rafi Ahmed +20 more

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2022009225
N/A
0DataRank · unranked
11 citations

Jeffrey M. Switchenko, Veronika Bachanová, James N. Gerson, Stefan K. Barta, Max J. Gordon +30 more